To determine if the observed trend in SMPD3 promoter methylation and expression was specific to our cohort or was representative of oral cancer more generally, we examined a publicly available TCGA data set of head and neck cancers profiled for both methylation (Illumina 450k array) and gene expression (Illumina HiSeq RNA-seq). The gene discussed is SMPD3; the disease is head and neck cancer.